Retigabine dihydrochloride Catalog No.:M9949-10 3-dihydro-1H-benzo[d]imidazol-5-yl)-2-methoxybenzamide

3-dihydro-1H-benzo[d]imidazol-5-yl)-2-methoxybenzamide

CAS Number: 348-67-4

and 200 mg/kg results in mean tumor regression of 92%

It promotes isolated rat liver mitochondrial energy metabolism

Smiles: CC1C=CC(=CC=1)S(=O)(=O)N[C@@H](CCCNC(N)=N)C(=O)OC

Retigabine dihydrochloride Catalog No.:M9949-10 3-dihydro-1H-benzo[d]imidazol-5-yl)-2-methoxybenzamideEzogabine, also known as Retigabine, is an anticonvulsant used as an adjunctive treatment for partial epilepsies in treatment experienced adult patients. The drug was developed by Valeant Pharmaceuticals and GlaxoSmithKline. Ezogabine works primarily as a potassium channel openerthat is, by activating a certain family of voltage gated potassium channels in the brain. This mechanism of action is unique among antiepileptic drugs, and may hold promise